Raqualia Pharma (4579 JP): 1H FY12/25 flash update
Operating revenue increased to JPY1.5bn (+8.9% YoY), with a net loss of JPY355mn and R&D expenses at JPY782mn. Royalty income from four...
232 Views
Raqualia Pharma (4579 JP): Q1 FY12/25 flash update
Operating revenue increased by 48.8% YoY to JPY965mn, with operating profit rising 109.2% YoY to JPY93mn. Royalty income from four products and...
320 Views
Raqualia Pharma (4579 JP): Q3 FY12/24 flash update
Operating revenue increased to JPY2.4bn (+58.4% YoY), with a net loss of JPY340mn, driven by rising R&D expenses. Royalty income from four...
198 Views
Raqualia Pharma (4579 JP): 1H FY12/24 flash update
Operating revenue increased to JPY1.4bn (+39.1% YoY), with an operating loss of JPY154mn and a recurring loss of JPY278mn. Royalty income from...
244 Views
Investment Thesis and Valuation
Key Drivers Stable income of ¥ 0.5b - ¥1b from Animal Healthcare segment Pharma segment – royalty income from Tegoprazan (South K approved June...
524 Views